• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An evaluation of the operational model when applied to quantify functional selectivity.评估操作模型在定量功能选择性时的应用。
Br J Pharmacol. 2018 May;175(10):1654-1668. doi: 10.1111/bph.14171. Epub 2018 Mar 30.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
An intact model for quantifying functional selectivity.一种用于量化功能选择性的完整模型。
Sci Rep. 2019 Feb 22;9(1):2557. doi: 10.1038/s41598-019-39000-z.
4
A method for the quantification of biased signalling at constitutively active receptors.一种用于量化组成性激活受体中偏向信号的方法。
Br J Pharmacol. 2018 Jun;175(11):2046-2062. doi: 10.1111/bph.14190. Epub 2018 Apr 25.
5
Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.G蛋白偶联受体上偏向激动剂动力学的建模与模拟
J Theor Biol. 2018 Apr 7;442:44-65. doi: 10.1016/j.jtbi.2018.01.010. Epub 2018 Jan 12.
6
A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses.具有不同最大反应的激动剂的偏性激动剂互补量表。
Sci Rep. 2017 Nov 13;7(1):15389. doi: 10.1038/s41598-017-15258-z.
7
Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivity.评估激动剂选择性时要注意七跨膜受体“客人”。
Br J Pharmacol. 2010 Jul;160(5):1045-7. doi: 10.1111/j.1476-5381.2010.00764.x.
8
ASAS-NANP symposium: Mathematical Modeling in Animal Nutrition: The power of identifiability analysis for dynamic modeling in animal science:a practitioner approach.ASAS-NANP 研讨会:动物营养中的数学建模:可识别性分析在动物科学动态建模中的作用:一种实践者的方法。
J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad320.
9
Parametric sensitivity analysis for biochemical reaction networks based on pathwise information theory.基于路径信息论的生化反应网络的参数灵敏度分析。
BMC Bioinformatics. 2013 Oct 22;14:311. doi: 10.1186/1471-2105-14-311.
10
Assessing parameter identifiability in compartmental dynamic models using a computational approach: application to infectious disease transmission models.使用计算方法评估房室动力学模型中的参数可识别性:在传染病传播模型中的应用。
Theor Biol Med Model. 2019 Jan 14;16(1):1. doi: 10.1186/s12976-018-0097-6.

引用本文的文献

1
Quantitative receptor model for responses that are left- or right-shifted versus occupancy (are more or less concentration sensitive): the SABRE approach.针对左移或右移反应与占有率(浓度敏感性或多或少)的定量受体模型:SABRE方法。
Front Pharmacol. 2023 Dec 15;14:1274065. doi: 10.3389/fphar.2023.1274065. eCollection 2023.
2
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB receptor.评估大麻素 CB 受体上合成大麻素受体激动剂的信号转导偏倚。
Pharmacol Res Perspect. 2023 Dec;11(6):e01157. doi: 10.1002/prp2.1157.
3
A single unified model for fitting simple to complex receptor response data.用于拟合简单到复杂受体反应数据的单一统一模型。
Sci Rep. 2020 Aug 7;10(1):13386. doi: 10.1038/s41598-020-70220-w.
4
Evaluation of the profiles of CB cannabinoid receptor signalling bias using joint kinetic modelling.使用联合动力学建模评估 CB 大麻素受体信号转导偏倚的特征。
Br J Pharmacol. 2020 Aug;177(15):3449-3463. doi: 10.1111/bph.15066. Epub 2020 May 15.
5
100 years of modelling ligand-receptor binding and response: A focus on GPCRs.100年的配体-受体结合与反应建模:聚焦于G蛋白偶联受体
Br J Pharmacol. 2020 Apr;177(7):1472-1484. doi: 10.1111/bph.14988. Epub 2020 Feb 28.
6
Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.有毒合成大麻素受体激动剂是否具有特征性的体外活性特征?以 AMB-FUBINACA 为例。
ACS Chem Neurosci. 2019 Oct 16;10(10):4350-4360. doi: 10.1021/acschemneuro.9b00429. Epub 2019 Sep 24.
7
A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data.一种针对复杂分数反应与占有率数据的具有结合亲和力、激活效力和信号放大参数的受体模型。
Front Pharmacol. 2019 Jun 11;10:605. doi: 10.3389/fphar.2019.00605. eCollection 2019.
8
An intact model for quantifying functional selectivity.一种用于量化功能选择性的完整模型。
Sci Rep. 2019 Feb 22;9(1):2557. doi: 10.1038/s41598-019-39000-z.
9
Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines.2,4,6-三取代-1,3,5-三嗪引发的大麻素受体2信号偏向性
Front Pharmacol. 2018 Nov 20;9:1202. doi: 10.3389/fphar.2018.01202. eCollection 2018.

本文引用的文献

1
A three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplification.一种包含亲和力、效能和信号放大的受体功能三参数双态模型。
Pharmacol Res Perspect. 2017 Apr 27;5(3):e00311. doi: 10.1002/prp2.311. eCollection 2017 Jun.
2
What do we mean by identifiability in mixed effects models?在混合效应模型中,可识别性是什么意思?
J Pharmacokinet Pharmacodyn. 2016 Feb;43(1):111-22. doi: 10.1007/s10928-015-9459-4. Epub 2015 Dec 10.
3
What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling.什么是有偏效性?定义内在效价与自由能耦合之间的关系。
Trends Pharmacol Sci. 2014 Dec;35(12):639-47. doi: 10.1016/j.tips.2014.09.010. Epub 2014 Oct 30.
4
A kinetic model of GPCRs: analysis of G protein activity, occupancy, coupling and receptor-state affinity constants.G蛋白偶联受体(GPCRs)的动力学模型:G蛋白活性、占有率、偶联及受体状态亲和常数分析
J Recept Signal Transduct Res. 2015;35(4):269-83. doi: 10.3109/10799893.2014.975250. Epub 2014 Oct 29.
5
A systems pharmacology perspective on the clinical development of Fatty Acid amide hydrolase inhibitors for pain.从系统药理学角度看脂肪酸酰胺水解酶抑制剂在疼痛治疗中的临床开发。
CPT Pharmacometrics Syst Pharmacol. 2014 Jan 15;3(1):e91. doi: 10.1038/psp.2013.72.
6
Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy.定量分析临床相关β2-肾上腺素能受体配体的配体偏向:对药物分类学的影响。
Mol Pharmacol. 2014 Mar;85(3):492-509. doi: 10.1124/mol.113.088880. Epub 2013 Dec 23.
7
Use of functional assays to detect and quantify functional selectivity.使用功能测定法来检测和量化功能选择性。
Drug Discov Today Technol. 2010 Spring;7(1):e1-e94. doi: 10.1016/j.ddtec.2010.07.001.
8
An approach for identifiability of population pharmacokinetic-pharmacodynamic models.一种群体药代动力学-药效学模型的可识别性方法。
CPT Pharmacometrics Syst Pharmacol. 2013 Jun 19;2(6):e49. doi: 10.1038/psp.2013.25.
9
Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology model.利用多尺度系统药理学模型预测随时间变化的骨矿物质密度的非线性变化。
CPT Pharmacometrics Syst Pharmacol. 2012 Nov 14;1(11):e14. doi: 10.1038/psp.2012.15.
10
Quantifying biased agonism: understanding the links between affinity and efficacy.量化偏向性激动作用:理解亲和力与效能之间的联系。
Nat Rev Drug Discov. 2013 Jun;12(6):483. doi: 10.1038/nrd3954-c1. Epub 2013 May 17.

评估操作模型在定量功能选择性时的应用。

An evaluation of the operational model when applied to quantify functional selectivity.

机构信息

Otago Pharmacometrics Group, National School of Pharmacy, University of Otago, Dunedin, New Zealand.

Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

出版信息

Br J Pharmacol. 2018 May;175(10):1654-1668. doi: 10.1111/bph.14171. Epub 2018 Mar 30.

DOI:10.1111/bph.14171
PMID:29457969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5913411/
Abstract

BACKGROUND AND PURPOSE

Functional selectivity describes the ability of ligands to differentially regulate multiple signalling pathways when coupled to a single receptor, and the operational model is commonly used to analyse these data. Here, we assess the mathematical properties of the operational model and evaluate the outcomes of fixing parameters on model performance.

EXPERIMENTAL APPROACH

The operational model was evaluated using both a mathematical identifiability analysis and simulation.

KEY RESULTS

Mathematical analysis revealed that the parameters R and K were not independently identifiable which can be solved by considering their ratio, τ. The ratio parameter, τ, was often imprecisely estimated when only functional assay data were available and generally only the transduction coefficient R ( τKA) could be estimated precisely. The general operational model (that includes baseline and the Hill coefficient) required either the parameters E or K to be fixed. The normalization process largely cancelled out the mean error of the calculated Δlog (R) caused by fixing these parameters. From this analysis, it was determined that we can avoid the need for a full agonist ligand to be included in an experiment to determine Δlog (R).

CONCLUSION AND IMPLICATIONS

This analysis has provided a ready-to-use understanding of current methods for quantifying functional selectivity. It showed that current methods are generally tolerant to fixing parameters. A new method was proposed that removes the need for including a high efficacy ligand in any given experiment, which allows application to large-scale screening to identify compounds with desirable features of functional selectivity.

摘要

背景与目的

功能选择性描述了配体与单个受体结合时,区分调节多个信号通路的能力,而操作模型通常用于分析这些数据。在这里,我们评估了操作模型的数学性质,并评估了固定参数对模型性能的影响。

实验方法

使用数学可识别性分析和模拟对操作模型进行了评估。

主要结果

数学分析表明,参数 R 和 K 不能独立识别,可以通过考虑它们的比值 τ 来解决。当仅具有功能测定数据时,比值参数 τ 通常估计不准确,通常只能准确估计转导系数 R(τKA)。一般的操作模型(包括基线和希尔系数)需要固定参数 E 或 K。归一化过程在很大程度上消除了由于固定这些参数而导致的计算 Δlog(R)的平均误差。通过该分析,确定可以避免在实验中包含完全激动剂配体来确定 Δlog(R)。

结论和意义

该分析为定量功能选择性的当前方法提供了易于理解的理解。它表明当前的方法通常对固定参数具有容忍性。提出了一种新方法,该方法不需要在任何给定的实验中包含高功效配体,从而允许应用于大规模筛选以识别具有功能选择性所需特征的化合物。